These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21370569)

  • 1. [Immunosuppressive agents in kidney transplantation].
    Nishi S
    Nihon Jinzo Gakkai Shi; 2011; 53(1):1-5. PubMed ID: 21370569
    [No Abstract]   [Full Text] [Related]  

  • 2. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
    Hanto DW; Chudzinski R
    Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
    [No Abstract]   [Full Text] [Related]  

  • 3. Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study.
    Ponticelli C; Salvadori M; Scolari MP; Citterio F; Rigotti P; Veneziano A; Bartezaghi M;
    Transplantation; 2011 May; 91(10):e72-3. PubMed ID: 21540717
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
    Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J
    Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-dose calcineurin inhibitor regimen combined with mammalian target of rapamycin inhibitors preserves kidney functions in renal transplant recipients without allograft nephropathy.
    Kacar S; Gurkan A; Karaca C; Varılsuha C; Tilif S
    Transplant Proc; 2010 Nov; 42(9):3513-6. PubMed ID: 21094806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus conversion for renal preservation in liver transplantation: not so fast.
    Jensen GS; Wiseman A; Trotter JF
    Liver Transpl; 2008 May; 14(5):601-3. PubMed ID: 18433068
    [No Abstract]   [Full Text] [Related]  

  • 7. Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
    Goldfarb DA
    J Urol; 2005 Jun; 173(6):2106-7. PubMed ID: 15879857
    [No Abstract]   [Full Text] [Related]  

  • 8. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
    Chapman JR; Nankivell BJ
    Nephrol Dial Transplant; 2006 Aug; 21(8):2060-3. PubMed ID: 16728428
    [No Abstract]   [Full Text] [Related]  

  • 9. Everolimus: efficacy and safety in cardiac transplantation.
    Schaffer SA; Ross HJ
    Expert Opin Drug Saf; 2010 Sep; 9(5):843-54. PubMed ID: 20701555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pro- and antitumor effects of the main immunosuppressive drugs used in the clinical practice of transplantation].
    Marchini F
    G Ital Nefrol; 2007; 24(2):171. PubMed ID: 17458835
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression without calcineurin inhibition: by ZEUS.
    Flechner SM
    Lancet; 2011 Mar; 377(9768):788-9. PubMed ID: 21334739
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular action mechanisms of the therapeutic agents for kidney diseases: Immunosuppressants].
    Nishikido M; Kanekake H; Harada T
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():634-8. PubMed ID: 16523968
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrolimus use in renal and cardiac pediatric transplantation: no increased risk of food allergies.
    Graham F; Racicot F; Jamali L; Cong VP; Raboisson MJ; Paradis J; Paradis L; Des Roches A
    Ann Allergy Asthma Immunol; 2015 Aug; 115(2):155-7. PubMed ID: 26094803
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
    Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
    Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept.
    Krisl JC; Alloway RR; Shields AR; Cardi MA; Woodle ES
    Transplantation; 2014 Feb; 97(4):e30-2. PubMed ID: 24531826
    [No Abstract]   [Full Text] [Related]  

  • 17. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
    Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
    Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations in sirolimus use in the early and late post-transplant periods.
    Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
    Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720.
    Weckbecker G; Pally C; Beerli C; Burkhart C; Wieczorek G; Metzler B; Morris RE; Wagner J; Bruns C
    Transpl Int; 2010 May; 23(5):543-52. PubMed ID: 20003043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
    Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.